Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Is It Castleman Disease, or Castleman-Like?

Philip Chu, MD, RhMSUS, Mithu Maheswaranathan, MD, Jadee L. Neff, MD, PhD, & Rebecca E. Sadun, MD, PhD  |  Issue: October 2021  |  October 13, 2021

Figure 1: Vague nodular areas (orange arrows) on the left and CD21 staining for follicular dendritic cells on the right demonstrate follicles with regressed germinal centers.

Figure 1: Vague nodular areas (orange arrows) on the left and CD21 staining for follicular dendritic cells on the right demonstrate follicles with regressed germinal centers.

The difference between Castle­man disease and Castleman-like disease may be subtle, but it comes with significant ramifications.

Case Presentation

This case involves a pregnant 19-year-old woman who presents over multiple hospitalizations with concerns for systemic lupus erythematosus and macrophage activation syndrome.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At 36 weeks’ gestation, the patient’s weight had dropped from 215 lbs. to 170 lbs., and she was observed to have a hyperpigmented macular rash on her trunk and extensor surface of the arms.

Laboratory values at her obstetrics clinic visit were notable for elevated total bili­rubin of 3.0 mg/dL (reference range [RR]: 0.4–1.5 mg/dL), aspartate aminotransferase (AST) 592 U/L (RR: 15–40 U/L), alanine aminotransferase (ALT) 245 U/L (RR: 14–50 U/L), alkaline phosphatase 155 U/L (RR: 24–110 U/L) and bile acids 107 umol/L (RR: 3.7–14.5 umol/L).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

She was admitted for further examination and testing, at which time she was noted to have elevated inflammatory markers with an erythrocyte sedimentation rate (ESR) of 65 mm/hour (RR: 0–15 mm/hr) and a C-reactive protein (CRP) of 2.8 mg/dL (RR: <0.60 mg/dL). Her ANA was 1:2560 titer in a homogeneous pattern, and complement levels were low: C3: 74 mg/dL (RR: 86–208 mg/dL); and C4: 12 mg/dL (RR: 13–47 mg/dL). Anti-Ro, anti-La, anti-Smith, anti-RNP, anti-dsDNA, anti-smooth muscle and anti-mitochondrial antibodies were negative.

Due to her significantly elevated bile acids, she was given betamethasone intramuscularly to accelerate fetal lung maturity, and underwent emergent Cesarean section. Her symptoms and laboratory values quickly improved, and she was discharged.

Four months later, she presented to the emergency department with abdominal pain, joint pain and a temperature of 103°F, at which time she was noted to have altered mentation with slow, circular speech. Her laboratory values were significant for hemo­globin of 7 g/dL (RR: 12–15 g/dL), haptoglobin 4 mg/dL (RR: 30–200 mg/dL), direct Coombs’ with IgG 3+ (normal=negative), normal creatinine, urinalysis with trace blood and a 24-hour urine protein of 2,200 mg/g (RR: <100 mg/g). Her inflammatory markers were markedly elevated, with ESR of 117 mm/hour (RR: 0–15 mm/hr), CRP 9.8 mg/dL (RR: <0.60 mg/dL) and ferritin greater than 15,000 ng/mL (RR: 10–200 ng/mL).

Cerebral spinal fluid (CSF) studies were noninflammatory with two nucleated cells x106/L (RR: 0–5×106/L), protein 11 mg/dL (RR: 15–50 mg/dL) and glucose 76 mg/dL. There were no CSF oligoclonal bands (normal: <4 bands) and infectious studies were negative.

Given the patient’s hyperferritinemia, there was concern for macrophage activation syndrome secondary to systemic lupus erythematosus (SLE).

She was treated with dexamethasone and subcutaneous anakinra with rapid improve­ment of abdominal pain, joint pain and mental status. Despite being drawn two days after immunosuppression was initiated, the soluble interleukin 2 receptor (sIL-2R) was elevated at 2,200 U/mL (RR: <1,100 U/mL. NK cell function was normal.

Given her degree of proteinuria, a renal biopsy was performed. It showed podocyte hypertrophy and effacement, without evidence of immune-complex-mediated disease, focal segmental glomerulosclerosis or thrombotic microangiopathy. Given the possibility of atypical renal involvement from SLE, she was prescribed myco­phenolate mofetil and prednisone (of note, patient’s baby was formula fed and not breastfed). Unfortunately, the patient did not follow up as an outpatient, and it was unclear whether she took the prescribed medications.

Two months later, the patient was found unresponsive at home after a generalized tonic-clonic seizure and brought by paramedics to the emergency department, with a temperature of 106°F, hypotensive and tachycardic. She was intubated, placed on a norepinephrine infusion and started on broad-spectrum empiric antibiotics. Other than the past medical history of SLE from recent months, she did not have known comorbidities.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportCastleman's disease

Related Articles

    Case Report: Diagnosing a Lupus-Flare Mimic

    August 12, 2020

    The diagnosis of rheumatic diseases requires the exclusion of other systemic disorders. Infection, hematologic conditions, malignancies and some drugs may all lead to syndromes that closely mimic rheumatic diseases, which may lead to diagnostic delays. Idiopathic multicentric Castleman disease (iMCD) is a heterogeneous group of lympho­proliferative diseases (LPDs) characterized by systemic inflammatory manifestations.1,2 As with…

    Rheumatology Case Report: Concomitant Lupus with Features of Scleroderma, Castleman Disease

    July 11, 2016

    We report a case of a 27-year-old woman who was initially diagnosed with systemic lupus erythematosus (SLE), had features of scleroderma and was subsequently found to have lymph node biopsy consistent with multicentric Castleman disease (MCD). She also had serologic evidence of acute Epstein-Barr virus (EBV) infection (vs. reactivation of EBV). The occurrence of MCD…

    A positron emission tomography (PET) scan shows a 3 cm, hypermetabolic mass adjacent to the stomach.

    Case Report: Elevated Inflammatory Markers & a Hypermetabolic Mass

    December 16, 2021

    Consulting rheumatologists often assess patients with atypical clinical presentations for the possibility of an underlying rheumatic disease. Inflammatory syndromes that are not clearly rheumatic in nature can be particularly challenging to diagnose. Here, we share the case of a young woman with a long-standing undiagnosed illness and highly elevated inflammatory markers, and describe the evaluation…

    Lupus often presents with a butterfly rash.

    Top 12: Research in Systemic Lupus Erythematosus at a Glance

    November 18, 2021

    Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences